Literature DB >> 24630834

ISG54 and ISG56 are induced by TLR3 signaling in U373MG human astrocytoma cells: possible involvement in CXCL10 expression.

Tadaatsu Imaizumi1, Akiko Numata2, Chikashi Yano2, Hidemi Yoshida2, Pengfei Meng2, Ryo Hayakari2, Fei Xing2, Lian Wang2, Tomoh Matsumiya2, Kunikazu Tanji3, Tetsuya Tatsuta4, Manabu Murakami5, Hiroshi Tanaka6.   

Abstract

Toll-like receptor (TLR) 3 is a pattern recognition receptor that recognizes double-stranded RNA (dsRNA). TLR3 signaling in astrocytes leads to the expression of interferon-β (IFN-β), and IFN-β regulates immune and inflammatory reactions by inducing IFN-stimulated genes (ISGs). We demonstrated in the present study that polyinosinic-polycytidylic acid (poly IC), an authentic dsRNA, up-regulated the expression of ISG54 and ISG56 in U373MG human astrocytoma cells. This reaction was confirmed to be mediated via the TLR3/IFN-β pathway. We also found that ISG56 positively regulates the expression of ISG54, retinoic acid-inducible gene-I (RIG-I) and melanoma differentiation-associated gene 5 (MDA5). In addition, positive feedback loops were found between ISG54 and ISG56, and also between ISG54 and RIG-I. RNA interference experiments revealed that all of ISG54, ISG56, RIG-I and MDA5 were involved in the poly IC-induced expression of a chemokine CXCL10. These results suggest that ISG54 and ISG56 are involved in the induction of CXCL10 in TLR3/IFN-β signaling at least partly by co-operating with RIG-I and MDA5. ISG54 and ISG56 may contribute to immune and inflammatory reactions elicited by the TLR3/IFN-β signaling pathway in astrocytes, and may play an important role both in antiviral immunity and in neuroinflammatory diseases.
Copyright © 2014 Elsevier Ireland Ltd and the Japan Neuroscience Society. All rights reserved.

Entities:  

Keywords:  CXCL10; IFN-β; ISG54; ISG56; TLR3; U373MG cells

Mesh:

Substances:

Year:  2014        PMID: 24630834     DOI: 10.1016/j.neures.2014.03.001

Source DB:  PubMed          Journal:  Neurosci Res        ISSN: 0168-0102            Impact factor:   3.304


  9 in total

Review 1.  Control of autoimmune CNS inflammation by astrocytes.

Authors:  Veit Rothhammer; Francisco J Quintana
Journal:  Semin Immunopathol       Date:  2015-07-30       Impact factor: 9.623

2.  RIG-I is required for VSV-induced cytokine production by murine glia and acts in combination with DAI to initiate responses to HSV-1.

Authors:  Emma K Crill; Samantha R Furr-Rogers; Ian Marriott
Journal:  Glia       Date:  2015-07-03       Impact factor: 7.452

3.  Discovery and Use of Long dsRNA Mediated RNA Interference to Stimulate Antiviral Protection in Interferon Competent Mammalian Cells.

Authors:  Shawna L Semple; Sarah K W Au; Rajesh A Jacob; Karen L Mossman; Stephanie J DeWitte-Orr
Journal:  Front Immunol       Date:  2022-05-06       Impact factor: 8.786

Review 4.  The effects of beta-endorphin: state change modification.

Authors:  Jan G Veening; Henk P Barendregt
Journal:  Fluids Barriers CNS       Date:  2015-01-29

5.  Intrahepatic Toll-Like Receptor 3 in Chronic HBV Infection Subjects: Asymptomatic Carriers, Active Chronic Hepatitis, Cirrhosis, and Hepatocellular Carcinoma.

Authors:  Jia Wen Yin; Mao Ping Huang; Bei Zhong
Journal:  Hepat Mon       Date:  2016-05-23       Impact factor: 0.660

6.  Ethanol induces interferon expression in neurons via TRAIL: role of astrocyte-to-neuron signaling.

Authors:  Colleen J Lawrimore; Leon G Coleman; Fulton T Crews
Journal:  Psychopharmacology (Berl)       Date:  2019-01-04       Impact factor: 4.530

7.  Antiviral effects of IFIT1 in human cytomegalovirus-infected fetal astrocytes.

Authors:  Li Zhang; Bin Wang; Ling Li; Dong-Meng Qian; Hong Yu; Mei-Lan Xue; Ming Hu; Xu-Xia Song
Journal:  J Med Virol       Date:  2016-09-09       Impact factor: 2.327

8.  Exosomes derived from HIV-1-infected cells promote growth and progression of cancer via HIV TAR RNA.

Authors:  Lechuang Chen; Zhimin Feng; Hong Yue; Douglas Bazdar; Uri Mbonye; Chad Zender; Clifford V Harding; Leslie Bruggeman; Jonathan Karn; Scott F Sieg; Bingcheng Wang; Ge Jin
Journal:  Nat Commun       Date:  2018-11-02       Impact factor: 14.919

Review 9.  A systematic review on poly(I:C) and poly-ICLC in glioblastoma: adjuvants coordinating the unlocking of immunotherapy.

Authors:  An Wouters; Evelien L J M Smits; Jorrit De Waele; Tias Verhezen; Sanne van der Heijden; Zwi N Berneman; Marc Peeters; Filip Lardon
Journal:  J Exp Clin Cancer Res       Date:  2021-06-25
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.